MetaCap

Latigo Biotherapeutics (LTGO) News

NASDAQ: LTGOHealth CareBiotechnology: Pharmaceutical PreparationsUSD

13.00-0.24 (-1.81%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

LTGO news summary

We found 3 recent headlines mentioning Latigo Biotherapeutics (LTGO): 0 in the past week and 3 in the past 30 days, most often from GlobeNewswire, Seeking Alpha. For price context, LTGO is down 1.81% at $13.00. The most recent story, "Latigo Biotherapeutics, Inc. GAAP EPS of -$0.55 beats by $0.12", was published by Seeking Alpha on Nov 5, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Latigo Biotherapeutics headlines

Compare LTGO